Complimentary Excerpt Available from Best Practices: Pharmaceutical Competitive Intelligence Excellence - Optimizing Data Collection within Approved ...( CHAPEL HILL N.C. April 23 /- Glob...),Health

CHAPEL HILL, N.C., April 23 /PRNewswire/ -- Global leaders are rediscovering the importance of strong competitive intelligence (CI) capabilities as a powerful tool for competing in today's economic environment, according to a new study by research firm Best Practices, LLC. The study further reveals -- Competitive Intelligence adds value and gains buy-in through the strategic process of transforming raw competitive data into actionable insights that have a financial impact for the company.

Pharmaceutical Competitive Intelligence Excellence: Optimizing Data Collection within Approved Guidelines -- Best Practices LLC's study explains how U.S. pharmaceutical and biotechnology organizations can optimize their CI operations while working within defined guidelines. The report also covers how CI groups work with legal groups to maximize the CI department's ability to deliver results.
Some key findings and Insights include:

-- Why multiple sources are vital to effective CI

-- People, Processes and Use of Third Party Vendors are Keys to Optimizing

Data Collection

-- How to manage internal expectations upfront

To access the full report or to download a complimentary summary containing insights found in this report, click on the following link: http://www3.best-in-class.com/rr933.htm .

To find out more about this report, or more about Best Practices Research and Consulting, please visit our website at http://www.best-in-class.com or contact Robert Naylor at 919-767-9244 or rnaylor@best-in-class.com

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companie
'/>"/>